Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate

From 2002 to 2003, a global pandemic of severe acute respiratory syndrome (SARS) spread to 5 continents and caused 8000 respiratory infections and 800 deaths. To ameliorate the effects of future outbreaks as well as to prepare for biodefense, a process for the production of a recombinant protein vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wen-Hsiang, Chag, Shivali M., Poongavanam, Mohan V., Biter, Amadeo B., Ewere, Ebe A., Rezende, Wanderson, Seid, Christopher A., Hudspeth, Elissa M., Pollet, Jeroen, McAtee, C. Patrick, Strych, Ulrich, Bottazzi, Maria Elena, Hotez, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612335/
https://www.ncbi.nlm.nih.gov/pubmed/28456726
http://dx.doi.org/10.1016/j.xphs.2017.04.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612335/
https://www.ncbi.nlm.nih.gov/pubmed/28456726
http://dx.doi.org/10.1016/j.xphs.2017.04.037

Ejemplares similares